Literature DB >> 10742562

Association of a myeloperoxidase promoter polymorphism with multiple sclerosis.

O H Kantarci1, E J Atkinson, D D Hebrink, C T McMurray, B G Weinshenker.   

Abstract

Myeloperoxidase (MPO) generates hypochlorous acid and other reactive oxygen intermediates leading to tissue damage. MPO is expressed in macrophages-microglia in multiple sclerosis (MS) lesions. A G-->A substitution that abolishes an SP1 transcription factor consensus sequence in the promoter reduces gene expression. We studied the association of the genetic variant with MS. We did not find an association with gender, age at onset, susceptibility to, or the course and severity of MS in a population-based sample of 122 patients from Olmsted County.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10742562     DOI: 10.1016/s0165-5728(00)00198-3

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  4 in total

Review 1.  Myeloperoxidase: A new player in autoimmunity.

Authors:  Anna Strzepa; Kirkwood A Pritchard; Bonnie N Dittel
Journal:  Cell Immunol       Date:  2017-05-10       Impact factor: 4.868

2.  Polymorphisms of tumor necrosis factor and myeloperoxidase genes in patients with chronic renal failure on peritoneal dialysis.

Authors:  Kinga Buraczynska; Maria Koziol-Montewka; Maria Majdan; Andrzej Ksiazek
Journal:  Mol Diagn       Date:  2003

3.  Genetic variation in the myeloperoxidase gene and cognitive impairment in multiple sclerosis.

Authors:  I Manna; P Valentino; A La Russa; F Condino; R Nisticò; M Liguori; A Clodomiro; V Andreoli; D Pirritano; R Cittadella; A Quattrone
Journal:  J Negat Results Biomed       Date:  2006-02-27

4.  A novel near-infrared fluorescent probe for rapid sensing of HClO in living cells and zebrafish.

Authors:  Liangliang Li; Xiaofeng Wang; Jinzhi Huang; Kaidong Ma; Xiaoyu Tan
Journal:  Front Chem       Date:  2022-09-21       Impact factor: 5.545

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.